SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001178913-24-000343
Filing Date
2024-02-01
Accepted
2024-02-01 08:03:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13-G zk2430871.htm SC 13G 66397
2 EXHIBIT 1 exhibit_1.htm EX-99 11685
  Complete submission text file 0001178913-24-000343.txt   79679
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-55457 | Film No.: 24585097
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 53 DERECH HA'SHALOM ST. GIVATAYIM L3 53454
Business Address 53 DERECH HA'SHALOM ST. GIVATAYIM L3 53454 972-3-733-2997
Phoenix Holdings Ltd. (Filed by) CIK: 0001679543 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G